← All diseases

Disease Atlas / Disease detail

Asbestosis

An atlas of progressive fibrosis after substantial asbestos exposure, exposure history, imaging and function, prevention, and supportive care.

asbestosis · asbestos pneumoconiosis

MONDO:0016466Public QA completeSource-bound · 4

Disease at a glance

Start with the essentials, then explore the patient and research views.

Public revision · 4d119a1ab28f

Disease class
Asbestosis is asbestos-caused pulmonary fibrosis.
Core mechanism
It usually follows substantial cumulative occupational exposure.
Genes or cause
Latency can span decades.
Typical features
Exertional dyspnea and dry cough are common.
Variability
Disease may progress after exposure stops.
Diagnosis
Diagnosis integrates exposure history, imaging, and lung function.
Management
High-resolution CT helps assess fibrosis.
Treatment and research
Other interstitial lung diseases require exclusion.
Reading evidence
No established treatment reverses fibrosis.
Key caution
Further exposure must be stopped.

For patients and families

A structured guide for understanding the disease and preparing for clinical conversations.

At a glance

Asbestosis is asbestos-caused pulmonary fibrosis.

Exertional dyspnea and dry cough are common.

How the disease works

It usually follows substantial cumulative occupational exposure.

Latency can span decades.

Why experiences vary

Disease may progress after exposure stops.

Diagnosis and management

Diagnosis integrates exposure history, imaging, and lung function.

Treatment status

High-resolution CT helps assess fibrosis.

Other interstitial lung diseases require exclusion.

Reading clinical trials

Lung function and associated cancer risks are monitored.

Topics for a clinical visit

Exposure duration, imaging, function, and occupational documentation require review.

Medical notice

This material is for disease education and is not a personal diagnosis or treatment instruction.

Evidence and sources

A trial registry status does not establish efficacy or regulatory approval.